Treatment of critical-sized bone defects: clinical and tissue engineering perspectives.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 29080923.
- Also identified by DOI 10.1007/s00590-017-2063-0.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Critical-sized bone defects are defined as those that will not heal spontaneously within a patient's lifetime. Current treatment options include vascularized bone grafts, distraction osteogenesis, and the induced membrane technique. The induced membrane technique is an increasingly utilized method with favorable results including high rates of union. Tissue engineering holds promise in the treatment of large bone defects due to advancement of stem cell biology, novel biomaterials, and 3D bioprinting. In this review, we provide an overview of the current operative treatment strategies of critical-sized bone defects as well as the current state of tissue engineering for such defects.
Medical subject headings
- Bone Diseases
- Tissue Engineering